Bioprocessing Research For Cellular Products

细胞产品的生物加工研究

基本信息

  • 批准号:
    BB/I016961/1
  • 负责人:
  • 金额:
    $ 42.81万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Research Grant
  • 财政年份:
    2011
  • 资助国家:
    英国
  • 起止时间:
    2011 至 无数据
  • 项目状态:
    已结题

项目摘要

This project aims to develop novel preservation platform technologies required for the successful banking of human cells, an absolute prerequisite for their use as products. Many regenerative medicine products rely on the delivery of live cells to patients. At present this is exemplified by established therapeutic interventions such as bone marrow transplantation, blood transfusion and corneal grafting; future generations of products may include bio-artificial matrices that incorporate donor stem cells, for example bone replacement and repair devices, and artificial 'mini-organs' such as pancreas or liver. Current cryopreservation of stem cell based products results from historic work, using DMSO as a cryopreserving agent which is largely unsubstantiated with respect to final biological activity. DMSO can be toxic to cells, lead to low viabilities post thaw and both genetic and epigenetic instability (i.e loss of pluripotency) over long term culture. Cryopreservation of blood cells has been attempted previously, with limited success due to loss of cell integrity, primarily due to the breakdown of the cell membrane and consequent loss of overall cell structure. A variety of techniques have been investigated for delivering trehalose, a membrane impermeable cryoprotectant, into mammalian cells, including microinjection, ion channel stimulation, pore formation using mutant bacterial toxins, fluid phase endocytosis, and internal trehalose synthesis via genetic engineering but intracellular trehalose concentrations achieved in erythrocytes has not exceeded 50 mM and is therefore below thresholds for cryoprotection. Biopolymer mediated cell loading achieves substantially increased intracellular trehalose concentrations of up to 251 mM and a concomitant improvement of erythrocyte cryosurvival of up to 20.4 % as compared with conventional methods of loading trehalose into cells. The technology utilizes novel amphiphilic biopolymers that interact with the external cell membrane to enable penetration and retention of cryoprotectant agents into the cells. Membrane permeabilisation by these Cell Permeating Polymers (CPPs) is rapid and completely reversible via washing with buffer. Cellular uptake of trehalose is dependent on polymer molecular structure, concentration, pH, external trehalose concentration, incubation temperature and time. Optimization of these parameters imparts cellular osmoprotection. Overall, a total cell recovery through a single freeze-thaw cycle at -80oC of 82.6 % has been achieved, which compares with a recovery of only 0.8 % for cells frozen in PBS. This proposal aims to explore the CPP mediated loading of preservation agents into stem cells, to examine preservation by freezing and dessication and to arrive at integrated processing routes for the preparation of optimally stable stem cells.
该项目旨在开发成功储存人类细胞所需的新型保存平台技术,这是将其用作产品的绝对先决条件。许多再生医学产品依赖于将活细胞输送给患者。目前,这是通过建立的治疗干预措施,如骨髓移植,输血和角膜移植;未来几代的产品可能包括生物人工基质,纳入供体干细胞,例如骨置换和修复设备,以及人造“微型器官”,如胰腺或肝脏。目前基于干细胞的产品的冷冻保存来自历史工作,使用DMSO作为冷冻保存剂,其在最终生物活性方面基本上未经证实。DMSO可能对细胞有毒,导致解冻后的低活力以及长期培养中的遗传和表观遗传不稳定性(即多能性丧失)。之前曾尝试过血细胞的冷冻保存,但由于细胞完整性的丧失(主要是由于细胞膜的破裂和随之而来的整体细胞结构的丧失),成功有限。已经研究了将海藻糖(一种膜不可渗透的冷冻保护剂)递送到哺乳动物细胞中的各种技术,包括显微注射、离子通道刺激、使用突变细菌毒素的孔形成、液相内吞作用和通过基因工程的内部海藻糖合成,但是在红细胞中实现的细胞内海藻糖浓度不超过50 mM,因此低于冷冻保护阈值。与将海藻糖装载到细胞中的常规方法相比,生物聚合物介导的细胞装载实现了高达251 mM的细胞内海藻糖浓度的显著增加以及高达20.4%的红细胞冷冻存活的伴随改善。该技术利用新型两亲性生物聚合物,与外部细胞膜相互作用,使冷冻保护剂渗透和保留到细胞中。通过这些细胞渗透聚合物(CPP)的膜渗透是快速的,并且通过用缓冲液洗涤是完全可逆的。海藻糖的细胞摄取取决于聚合物分子结构、浓度、pH、外部海藻糖浓度、孵育温度和时间。这些参数的优化赋予了细胞凋亡保护。总体而言,在-80 ° C下通过单个冻融循环实现了82.6%的总细胞回收率,相比之下,在PBS中冷冻的细胞的回收率仅为0.8%。该提案旨在探索CPP介导的将保存剂加载到干细胞中,通过冷冻和干燥检查保存,并获得用于制备最佳稳定干细胞的综合处理路线。

项目成果

期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Amphipathic polymer-mediated uptake of trehalose for dimethyl sulfoxide-free human cell cryopreservation.
  • DOI:
    10.1016/j.cryobiol.2013.09.002
  • 发表时间:
    2013-12
  • 期刊:
  • 影响因子:
    2.7
  • 作者:
    Sharp, Duncan M. C.;Picken, Andrew;Morris, Timothy J.;Hewitt, Christopher J.;Coopman, Karen;Slater, Nigel K. H.
  • 通讯作者:
    Slater, Nigel K. H.
DMSO-FREE CRYOPRESERVATION OF PANCREATIC ISLETS USING TREHALOSE AND MEMBRANE-PERMEABILISING BIOPOLYMER PP-50
使用海藻糖和膜渗透生物聚合物 PP-50 对胰岛进行无 DMSO 冷冻保存
  • DOI:
  • 发表时间:
    2017
  • 期刊:
  • 影响因子:
    3.1
  • 作者:
    Dolezalova Nikola
  • 通讯作者:
    Dolezalova Nikola
The effect of Me$_{2}$SO overexposure during cryopreservation on HOS TE85 and hMSC viability, growth and quality
冷冻保存过程中 Me$_{2}$SO 过度暴露对 HOS TE85 和 hMSC 活力、生长和质量的影响
  • DOI:
    10.17863/cam.7994
  • 发表时间:
    2016
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Morris T
  • 通讯作者:
    Morris T
The intracellular fate of an amphipathic pH-responsive polymer: Key characteristics towards drug delivery.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Nigel Slater其他文献

Correction: Middle Eastern nurses’ views/experiences of work and well-being with the support measures during past disease outbreaks and COVID-19: a qualitative systematic review
  • DOI:
    10.1186/s12912-024-02429-3
  • 发表时间:
    2024-10-10
  • 期刊:
  • 影响因子:
    3.900
  • 作者:
    Sara Ahmed Marair;Nigel Slater
  • 通讯作者:
    Nigel Slater
On/off switchable epicatechin-based ultra-sensitive MRI-visible nanotheranostics – see it and treat it
开/关可切换的基于表儿茶素的超灵敏 MRI 可见纳米治疗学 — 查看并治疗它
  • DOI:
    10.1039/d0bm00842g
  • 发表时间:
    2020
  • 期刊:
  • 影响因子:
    6.6
  • 作者:
    Bing Xiao;Xiaoxuan Zhou;Hongxia Xu;Wei Zhang;Xiaodan Xu;Fengjuan Tian;Yue Qian;Feidan Yu;Cailing Pu;Hongjie Hu;Zhuxian Zhou;Xiangrui Liu;Hirak K. Patra;Nigel Slater;Jianbin Tang;Jianqing Gao;Youqing Shen
  • 通讯作者:
    Youqing Shen
The effects in rats of lisdexamfetamine in combination with olanzapine on mesocorticolimbic dopamine efflux, striatal dopamine D<sub>2</sub> receptor occupancy and stimulus generalization to a <span class="small-caps">d</span>-amphetamine cue
  • DOI:
    10.1016/j.neuropharm.2015.09.014
  • 发表时间:
    2016-02-01
  • 期刊:
  • 影响因子:
  • 作者:
    Peter H. Hutson;Helen L. Rowley;James Gosden;Rajiv S. Kulkarni;Nigel Slater;Patrick L. Love;Yiyun Wang;David Heal
  • 通讯作者:
    David Heal
Investigation of the κ-opioid receptor agonist cr845 and reference comparator, butorphanol, in rats trained to discriminate (−)pentazocine from saline
  • DOI:
    10.1016/j.drugalcdep.2016.08.244
  • 发表时间:
    2017-02-01
  • 期刊:
  • 影响因子:
  • 作者:
    David John Heal;Jane Gosden;Nigel Slater;Robert H. Spencer;Frédérique Menzaghi
  • 通讯作者:
    Frédérique Menzaghi
Investigation of the Discriminative and Reinforcing Properties of the κ-opioid Receptor Agonist CR845 in Rats
  • DOI:
    10.1016/j.vascn.2017.09.078
  • 发表时间:
    2017-11-01
  • 期刊:
  • 影响因子:
  • 作者:
    Sharon Smith;Jane Gosden;Nigel Slater;Steve Holland;Julie Slade;Rob Spencer;Frédérique Menzaghi;David Heal
  • 通讯作者:
    David Heal

Nigel Slater的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Nigel Slater', 18)}}的其他基金

BRIC 2008: Bioprocess intensification by microcapillary separations systems
金砖四国 2008:通过微毛细管分离系统强化生物过程
  • 批准号:
    BB/G010226/1
  • 财政年份:
    2009
  • 资助金额:
    $ 42.81万
  • 项目类别:
    Research Grant
ORT-VAC: live bacterial vectors for vaccine delivery
ORT-VAC:用于疫苗递送的活细菌载体
  • 批准号:
    DT/F002343/1
  • 财政年份:
    2008
  • 资助金额:
    $ 42.81万
  • 项目类别:
    Research Grant
BRIC: Packaging cell lines for inherently manufacturable viral vectors
金砖四国:用于固有可制造病毒载体的包装细胞系
  • 批准号:
    BB/E005853/1
  • 财政年份:
    2007
  • 资助金额:
    $ 42.81万
  • 项目类别:
    Research Grant
Spontaneously Biotinylated Lentiviral Vectors For Envelope Independent Targeting Of Infection
用于独立包膜感染靶向的自发生物素化慢病毒载体
  • 批准号:
    BB/D007933/1
  • 财政年份:
    2006
  • 资助金额:
    $ 42.81万
  • 项目类别:
    Research Grant
Second Generation Bio-Lentivir Packaging Cell Line for Facile Lentivirus Production
用于轻松生产慢病毒的第二代生物慢病毒包装细胞系
  • 批准号:
    EP/D000599/1
  • 财政年份:
    2006
  • 资助金额:
    $ 42.81万
  • 项目类别:
    Research Grant

相似国自然基金

Research on Quantum Field Theory without a Lagrangian Description
  • 批准号:
    24ZR1403900
  • 批准年份:
    2024
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
Cell Research
  • 批准号:
    31224802
  • 批准年份:
    2012
  • 资助金额:
    24.0 万元
  • 项目类别:
    专项基金项目
Cell Research
  • 批准号:
    31024804
  • 批准年份:
    2010
  • 资助金额:
    24.0 万元
  • 项目类别:
    专项基金项目
Cell Research (细胞研究)
  • 批准号:
    30824808
  • 批准年份:
    2008
  • 资助金额:
    24.0 万元
  • 项目类别:
    专项基金项目
Research on the Rapid Growth Mechanism of KDP Crystal
  • 批准号:
    10774081
  • 批准年份:
    2007
  • 资助金额:
    45.0 万元
  • 项目类别:
    面上项目

相似海外基金

Collaborative Research: NSF-BSF: How cell adhesion molecules control neuronal circuit wiring: Binding affinities, binding availability and sub-cellular localization
合作研究:NSF-BSF:细胞粘附分子如何控制神经元电路布线:结合亲和力、结合可用性和亚细胞定位
  • 批准号:
    2321481
  • 财政年份:
    2024
  • 资助金额:
    $ 42.81万
  • 项目类别:
    Continuing Grant
Collaborative Research: NSF-BSF: How cell adhesion molecules control neuronal circuit wiring: Binding affinities, binding availability and sub-cellular localization
合作研究:NSF-BSF:细胞粘附分子如何控制神经元电路布线:结合亲和力、结合可用性和亚细胞定位
  • 批准号:
    2321480
  • 财政年份:
    2024
  • 资助金额:
    $ 42.81万
  • 项目类别:
    Continuing Grant
REU Site in Cellular and Molecular Biology at Sanford Research
桑福德研究中心细胞和分子生物学 REU 网站
  • 批准号:
    2243400
  • 财政年份:
    2024
  • 资助金额:
    $ 42.81万
  • 项目类别:
    Standard Grant
Collaborative Research: NeTS: Medium: EdgeRIC: Empowering Real-time Intelligent Control and Optimization for NextG Cellular Radio Access Networks
合作研究:NeTS:媒介:EdgeRIC:为下一代蜂窝无线接入网络提供实时智能控制和优化
  • 批准号:
    2312978
  • 财政年份:
    2023
  • 资助金额:
    $ 42.81万
  • 项目类别:
    Standard Grant
Collaborative Research: Cellular and Biomechanical Mechanisms of Rapid Stomatal Dynamics in Grasses
合作研究:草类快速气孔动力学的细胞和生物力学机制
  • 批准号:
    2327732
  • 财政年份:
    2023
  • 资助金额:
    $ 42.81万
  • 项目类别:
    Standard Grant
Collaborative Research: Alpha-arrestins' impact on cellular physiology
合作研究:α-抑制蛋白对细胞生理学的影响
  • 批准号:
    2321625
  • 财政年份:
    2023
  • 资助金额:
    $ 42.81万
  • 项目类别:
    Standard Grant
CDS&E/Collaborative Research: Data-Driven Inverse Design of Additively Manufacturable Aperiodic Architected Cellular Materials
CDS
  • 批准号:
    2245298
  • 财政年份:
    2023
  • 资助金额:
    $ 42.81万
  • 项目类别:
    Standard Grant
Collaborative Research: Alpha-arrestins' impact on cellular physiology
合作研究:α-抑制蛋白对细胞生理学的影响
  • 批准号:
    2321624
  • 财政年份:
    2023
  • 资助金额:
    $ 42.81万
  • 项目类别:
    Standard Grant
Collaborative Research: MoDL: Graph-Optimized Cellular Connectionism via Artificial Neural Networks for Data-Driven Modeling and Optimization of Complex Systems
合作研究:MoDL:通过人工神经网络进行图优化的细胞连接,用于复杂系统的数据驱动建模和优化
  • 批准号:
    2234032
  • 财政年份:
    2023
  • 资助金额:
    $ 42.81万
  • 项目类别:
    Standard Grant
2023 Molecular and Cellular Biology of Lipids Gordon Research Conference and Gordon Research Seminar
2023脂质分子与细胞生物学戈登研究会议暨戈登研究研讨会
  • 批准号:
    10609279
  • 财政年份:
    2023
  • 资助金额:
    $ 42.81万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了